Literature DB >> 10867010

Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase.

C Kronman1, T Chitlaru, E Elhanany, B Velan, A Shafferman.   

Abstract

The tetrameric form of native serum-derived bovine acetylcholinesterase is retained in the circulation for much longer periods (mean residence time, MRT = 1390 min) than recombinant bovine acetylcholinesterase (rBoAChE) produced in the HEK-293 cell system (MRT = 57 min). Extensive matrix-assisted laser desorption ionization-time of flight analyses established that the basic structures of the N-glycans associated with the native and recombinant enzymes are similar (the major species (50-60%) are of the biantennary fucosylated type and 20-30% are of the triantennary type), yet the glycan termini of the native enzyme are mostly capped with sialic acid (82%) and alpha-galactose (12%), whereas glycans of the recombinant enzyme exhibit a high level of exposed beta-galactose residues (50%) and a lack of alpha-galactose. Glycan termini of both fetal bovine serum and rBoAChE were altered in vitro using exoglycosidases and sialyltransferase or in vivo by a HEK-293 cell line developed specifically to allow efficient sialic acid capping of beta-galactose-exposed termini. In addition, the dimeric and monomeric forms of rBoAChE were quantitatively converted to tetramers by complexation with a synthetic peptide representing the human ColQ-derived proline-rich attachment domain. Thus by controlling both the level and nature of N-glycan capping and subunit assembly, we generated and characterized 9 distinct bovine AChE glycoforms displaying a 400-fold difference in their circulatory lifetimes (MRT = 3.5-1390 min). This revealed some general rules and a hierarchy of post-translation factors determining the circulatory profile of glycoproteins. Accordingly, an rBoAChE was generated that displayed a circulatory profile indistinguishable from the native form.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867010     DOI: 10.1074/jbc.M004298200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents.

Authors:  Brian C Geyer; Latha Kannan; Pierre-Emmanuel Garnaud; Clarence A Broomfield; C Linn Cadieux; Irene Cherni; Sean M Hodgins; Shane A Kasten; Karli Kelley; Jacquelyn Kilbourne; Zeke P Oliver; Tamara C Otto; Ian Puffenberger; Tony E Reeves; Neil Robbins; Ryan R Woods; Hermona Soreq; David E Lenz; Douglas M Cerasoli; Tsafrir S Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

2.  Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Authors:  Denis G Ilyushin; Ivan V Smirnov; Alexey A Belogurov; Igor A Dyachenko; Tatiana Iu Zharmukhamedova; Tatjana I Novozhilova; Eugene A Bychikhin; Marina V Serebryakova; Oleg N Kharybin; Arkadii N Murashev; Konstantin A Anikienko; Eugene N Nikolaev; Natalia A Ponomarenko; Dmitry D Genkin; G Michael Blackburn; Patrick Masson; Alexander G Gabibov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

3.  Effect of human acetylcholinesterase subunit assembly on its circulatory residence.

Authors:  T Chitlaru; C Kronman; B Velan; A Shafferman
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

Review 4.  Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.

Authors:  Yvonne Rosenberg; Ashima Saxena
Journal:  Neuropharmacology       Date:  2020-05-19       Impact factor: 5.250

Review 5.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

6.  Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity.

Authors:  O Cohen; C Kronman; T Chitlaru; A Ordentlich; B Velan; A Shafferman
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

7.  Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase.

Authors:  Michelle N Ngamelue; Kohei Homma; Oksana Lockridge; Oluwatoyin A Asojo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-10

8.  Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase.

Authors:  Lei Fang; Shurong Hou; Liu Xue; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2014-02-25       Impact factor: 5.192

9.  Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath.

Authors:  Tama Evron; Brian C Geyer; Irene Cherni; Mrinalini Muralidharan; Jacquelyn Kilbourne; Samuel P Fletcher; Hermona Soreq; Tsafrir S Mor
Journal:  FASEB J       Date:  2007-05-02       Impact factor: 5.191

10.  Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).

Authors:  Ofer Cohen; Chanoch Kronman; Baruch Velan; Avigdor Shafferman
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.